Form D · Biotechnology
ATRITECH INC
Plymouth, MN · CIK 0001120942
Offering snapshot reported Mar 26, 2009 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2009 | Initial | $30,000,000 | No comparison | Not reported | SEC filing |
| Mar 16, 2006 | Paper | Not reported | No comparison | Not reported | |
| Jun 3, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-56791
Source: Form D, filed Mar 26, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Bullock | Director, Executive |
| Lyle Hohnke | Director |
| Pete Mc Nerney | Director |
| Gordon Nye | Director |
| David Stassen | Director |
| Brad Swatfager | Executive |
| Robert Van Tassel Md | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3750 Annapolis Lane Suite 105
Plymouth, MN, 55447
Plymouth, MN, 55447